
Makes even dry topics interesting.
Creates a safe and inclusive space.
This comment is not public.
Brings enthusiasm to every interaction.
Creates a welcoming and inclusive environment.
Great Professor!
Dr Vicki Maltby is a Conjoint Senior Lecturer in the School of Medicine and Public Health, College of Health, Medicine and Wellbeing, at the University of Newcastle, Australia. She holds the position of Senior Scientific Officer in Neurology at John Hunter Hospital, Hunter New England Health, since 1 January 2020. Previously, she served as a Post Doctoral Fellow in the School of Biomedical Sciences and Pharmacy at the University of Newcastle from 20 March 2012 to 31 December 2018, and as a Technician at the Pacific Agri-Food Research Centre from 1 May to 1 September 2004. Dr Maltby earned her PhD and Bachelor of Science from the University of British Columbia, Canada. Her teaching expertise includes Basic Genetics.
Dr Maltby's research expertise is in Epigenetics and Medical Genetics, with fields of research allocated as 80% Epigenetics (including genome methylation and epigenomics), 10% Immunogenetics (including genetic immunology), and 10% Cognition. Her work examines epigenetic mechanisms underlying multiple sclerosis (MS), including genome-wide DNA methylation changes in CD19+ B cells from relapsing-remitting MS patients, increased DNA methylation of SLFN12 in CD4+ and CD8+ T cells from MS patients, epigenetic differences at the HTR2A locus in progressive MS patients, whole-blood methylation signatures associated with MS disease severity, and biological mechanisms of pregnancy's lasting effect on MS outcomes. Key publications include Jacobs BM, Vandebergh M, Maltby VE, Dobson R, Kreft KL, 'Interplay between genetic and environmental risk factors in multiple sclerosis: what have we learned?', Brain (2026); Maltby VE, Scott RJ, Giovannoni G, Hawkes CH, Levy M, Yeh EA, Lechner-Scott J, 'Where does multiple sclerosis come from?', Multiple Sclerosis and Related Disorders 85 (2024); Maltby VE et al., 'Efficacy of Cladribine Tablets as a Treatment for People With Multiple Sclerosis: Protocol for the CLOBAS Study', JMIR Research Protocols 10 (2021); Maltby VE et al., 'Genome-wide DNA methylation profiling of CD8+ T cells shows a distinct epigenetic signature to CD4+ T cells in multiple sclerosis patients', Clinical Epigenetics 7 (2015). Dr Maltby has authored 49 journal articles and delivered 55 conference presentations.

Photo by MAK on Unsplash
Have a story or a research paper to share? Become a contributor and publish your work on AcademicJobs.com.
Submit your Research - Make it Global News